GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1992 | 12-1991 | 09-1991 | 06-1991 | 03-1991 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,870 | 4,400 | 4,160 | 3,960 | 4,270 |
| Marketable Securities | 250 | N/A | 130 | 460 | 290 |
| Receivables | 20 | 50 | 730 | 230 | 40 |
| Inventories | 120 | 110 | 80 | 90 | 100 |
| Other current assets | 70 | 50 | 80 | 100 | 70 |
| TOTAL | $4,330 | $4,610 | $5,180 | $4,840 | $4,770 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $4,550 | $4,770 | $5,310 | $4,970 | $4,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $50 | $160 | $600 | $230 | $90 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $50 | $160 | $600 | $230 | $90 |
| Shareholders' Equity | |||||
| Common Shares | 15,350 | 15,350 | 15,350 | 15,350 | 15,350 |
| Retained earnings | -10,850 | -10,740 | -10,640 | -10,600 | -10,540 |
| Other shareholders' equity | -10 | -10 | 0 | -10 | -10 |
| TOTAL | $4,490 | $4,600 | $4,710 | $4,740 | $4,800 |
| Total Liabilities And Equity | $4,540 | $4,760 | $5,310 | $4,970 | $4,890 |